Search details
1.
Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma.
J Cell Mol Med
; 23(4): 2711-2718, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30784173
2.
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
J Biol Chem
; 293(8): 2877-2887, 2018 02 23.
Article
in English
| MEDLINE | ID: mdl-29326164
3.
Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).
Genes Dev
; 25(12): 1245-61, 2011 Jun 15.
Article
in English
| MEDLINE | ID: mdl-21646373
4.
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.
Br J Cancer
; 117(7): 947-953, 2017 Sep 26.
Article
in English
| MEDLINE | ID: mdl-28850564
5.
Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Nature
; 531(7592): 126, 2016 Mar 03.
Article
in English
| MEDLINE | ID: mdl-26633630
6.
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Nature
; 480(7375): 94-8, 2011 Oct 19.
Article
in English
| MEDLINE | ID: mdl-22012259
7.
Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?
Biomedicines
; 12(2)2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-38397987
8.
Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.
J Biol Chem
; 287(35): 29887-98, 2012 Aug 24.
Article
in English
| MEDLINE | ID: mdl-22767597
9.
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
Autophagy
; 19(10): 2800-2806, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37482676
10.
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma.
Commun Biol
; 4(1): 166, 2021 02 05.
Article
in English
| MEDLINE | ID: mdl-33547392
11.
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness.
Theranostics
; 9(3): 661-675, 2019.
Article
in English
| MEDLINE | ID: mdl-30809300
12.
Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5.
Theranostics
; 9(4): 1181-1199, 2019.
Article
in English
| MEDLINE | ID: mdl-30867824
13.
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments.
Theranostics
; 9(18): 5332-5346, 2019.
Article
in English
| MEDLINE | ID: mdl-31410218
14.
Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.
Theranostics
; 8(9): 2447-2458, 2018.
Article
in English
| MEDLINE | ID: mdl-29721091
15.
Structural and functional analysis of coral Hypoxia Inducible Factor.
PLoS One
; 12(11): e0186262, 2017.
Article
in English
| MEDLINE | ID: mdl-29117182
16.
Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas.
Cancer Res
; 77(5): 1212-1226, 2017 03 01.
Article
in English
| MEDLINE | ID: mdl-28087600
17.
FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells.
Sci Rep
; 6: 36539, 2016 11 09.
Article
in English
| MEDLINE | ID: mdl-27827420
18.
Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth.
Cancer Res
; 76(15): 4481-92, 2016 08 01.
Article
in English
| MEDLINE | ID: mdl-27302165
19.
Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux.
Autophagy
; 11(10): 1891-904, 2015.
Article
in English
| MEDLINE | ID: mdl-26312386
20.
Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation.
Cancer Metab
; 3: 8, 2015.
Article
in English
| MEDLINE | ID: mdl-26322231